Post-pandemic Era-Global Chronic Urticaria Or Hives Drug Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

Table of Contents

Global Chronic Urticaria Or Hives Drug Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

1 Market Scope

• 1.1 Product Details and Introduction
  • 1.1.1 GDC-0853 -Product Introduction and Major Manufacturers
  • 1.1.2 GSK-2646264 -Product Introduction and Major Manufacturers
  • 1.1.3 BF-Derm-1 -Product Introduction and Major Manufacturers
  • 1.1.4 Bilastine -Product Introduction and Major Manufacturers
  • 1.1.5 Others -Product Introduction and Major Manufacturers
• 1.2 Market Snapshot
  • 1.2.1 Major Companies Overview
  • 1.2.2 Market Concentration
  • 1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

2 Regional Market Analysis

• 2.1 China Chronic Urticaria Or Hives Drug Status and Prospect (2016-2027)
  • 2.1.1 China Chronic Urticaria Or Hives Drug Market Size and Growth Rate (2016-2027)
  • 2.1.2 China Chronic Urticaria Or Hives Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
• 2.2 EU Chronic Urticaria Or Hives Drug Status and Prospect (2016-2027)
  • 2.2.1 EU Chronic Urticaria Or Hives Drug Market Size and Growth Rate (2016-2027)
  • 2.2.2 EU Chronic Urticaria Or Hives Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
• 2.3 USA Chronic Urticaria Or Hives Drug Status and Prospect (2016-2027)
  • 2.3.1 USA Chronic Urticaria Or Hives Drug Market Size and Growth Rate (2016-2027)
  • 2.3.2 USA Chronic Urticaria Or Hives Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
• 2.4 Japan Chronic Urticaria Or Hives Drug Status and Prospect (2016-2027)
  • 2.4.1 Japan Chronic Urticaria Or Hives Drug Market Size and Growth Rate (2016-2027)
  • 2.4.2 Japan Chronic Urticaria Or Hives Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
• 2.5 India Chronic Urticaria Or Hives Drug Status and Prospect (2016-2027)
  • 2.5.1 India Chronic Urticaria Or Hives Drug Market Size and Growth Rate (2016-2027)
  • 2.5.2 India Chronic Urticaria Or Hives Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
• 2.6 Southeast Asia Chronic Urticaria Or Hives Drug Status and Prospect (2016-2027)
  • 2.6.1 Southeast Asia Chronic Urticaria Or Hives Drug Market Size and Growth Rate (2016-2027)
  • 2.6.2 Southeast Asia Chronic Urticaria Or Hives Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
• 2.7 South America Chronic Urticaria Or Hives Drug Status and Prospect (2016-2027)
  • 2.7.1 South America Chronic Urticaria Or Hives Drug Market Size and Growth Rate (2016-2027)
  • 2.7.2 South America Chronic Urticaria Or Hives Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
• 2.8 Chronic Urticaria Or Hives Drug Status and Prospect (2016-2027)
  • 2.8.1 Chronic Urticaria Or Hives Drug Market Size and Growth Rate (2016-2027)
  • 2.8.2 Chronic Urticaria Or Hives Drug Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

3 Global Chronic Urticaria Or Hives Drug Market Assessment by Segment

• 3.1 Global Chronic Urticaria Or Hives Drug Capacity and Growth Rate
• 3.2 Global Chronic Urticaria Or Hives Drug Sales by Type
• 3.3 Global Chronic Urticaria Or Hives Drug Sales Revenue by Type
• 3.4 Global Chronic Urticaria Or Hives Drug Consumption by Application

4 Global Chronic Urticaria Or Hives Drug Market Assessment by Regions

• 4.1 Global Chronic Urticaria Or Hives Drug Production Analysis and Forecast by Regions (2016-2027)
• 4.2 Global Chronic Urticaria Or Hives Drug Sales Analysis and Forecast by Regions (2016-2027)
• 4.3 Global Chronic Urticaria Or Hives Drug Sales Revenue Analysis and Forecast by Regions (2016-2027)

5 Value Chain (Impact of COVID-19)

• 5.1 Chronic Urticaria Or Hives Drug Value Chain Analysis
  • 5.1.1 Upstream
  • 5.1.2 Downstream
• 5.2 COVID-19 Impact on Chronic Urticaria Or Hives Drug Industry
  • 5.2.1 Industrial Policy Issued Under the Epidemic Situation
• 5.3 Cost-Under the Epidemic Situation
  • 5.3.1 Cost of Raw Material
• 5.4 Channel Analysis
  • 5.4.1 Distribution Channel-Under the Epidemic Situation
  • 5.4.2 Distributors

6 Competitive Landscape

• 6.1 Global Chronic Urticaria Or Hives Drug Capacity Market Share of Manufacturers (2019-2020)
• 6.2 Global Chronic Urticaria Or Hives Drug Sales Market Share of Manufacturers (2019-2020)
• 6.3 Global Chronic Urticaria Or Hives Drug Sales Revenue Market Share of Manufacturers (2019-2020)

7 Chronic Urticaria Or Hives Drug Competitive Analysis

• 7.1 AstraZeneca Plc
  • 7.1.1 AstraZeneca Plc Company Profiles
  • 7.1.2 AstraZeneca Plc Product Introduction
  • 7.1.3 AstraZeneca Plc Chronic Urticaria Or Hives Drug Production, Revenue (2015-2020)
  • 7.1.4 SWOT Analysis
• 7.2 Biofrontera AG
  • 7.2.1 Biofrontera AG Company Profiles
  • 7.2.2 Biofrontera AG Product Introduction
  • 7.2.3 Biofrontera AG Chronic Urticaria Or Hives Drug Production, Revenue (2015-2020)
  • 7.2.4 SWOT Analysis
• 7.3 ELORAC, Inc.
  • 7.3.1 ELORAC, Inc. Company Profiles
  • 7.3.2 ELORAC, Inc. Product Introduction
  • 7.3.3 ELORAC, Inc. Chronic Urticaria Or Hives Drug Production, Revenue (2015-2020)
  • 7.3.4 SWOT Analysis
• 7.4 Faes Farma, SA
  • 7.4.1 Faes Farma, SA Company Profiles
  • 7.4.2 Faes Farma, SA Product Introduction
  • 7.4.3 Faes Farma, SA Chronic Urticaria Or Hives Drug Production, Revenue (2015-2020)
  • 7.4.4 SWOT Analysis
• 7.5 Genentech, Inc.
  • 7.5.1 Genentech, Inc. Company Profiles
  • 7.5.2 Genentech, Inc. Product Introduction
  • 7.5.3 Genentech, Inc. Chronic Urticaria Or Hives Drug Production, Revenue (2015-2020)
  • 7.5.4 SWOT Analysis
• 7.6 GlaxoSmithKline Plc
  • 7.6.1 GlaxoSmithKline Plc Company Profiles
  • 7.6.2 GlaxoSmithKline Plc Product Introduction
  • 7.6.3 GlaxoSmithKline Plc Chronic Urticaria Or Hives Drug Production, Revenue (2015-2020)
  • 7.6.4 SWOT Analysis
• 7.7 J Uriach Y Compania, S.A.
  • 7.7.1 J Uriach Y Compania, S.A. Company Profiles
  • 7.7.2 J Uriach Y Compania, S.A. Product Introduction
  • 7.7.3 J Uriach Y Compania, S.A. Chronic Urticaria Or Hives Drug Production, Revenue (2015-2020)
  • 7.7.4 SWOT Analysis
• 7.8 Mabtech Limited
  • 7.8.1 Mabtech Limited Company Profiles
  • 7.8.2 Mabtech Limited Product Introduction
  • 7.8.3 Mabtech Limited Chronic Urticaria Or Hives Drug Production, Revenue (2015-2020)
  • 7.8.4 SWOT Analysis
• 7.9 Merck & Co., Inc.
  • 7.9.1 Merck & Co., Inc. Company Profiles
  • 7.9.2 Merck & Co., Inc. Product Introduction
  • 7.9.3 Merck & Co., Inc. Chronic Urticaria Or Hives Drug Production, Revenue (2015-2020)
  • 7.9.4 SWOT Analysis
• 7.10 Mycenax Biotech Inc.
  • 7.10.1 Mycenax Biotech Inc. Company Profiles
  • 7.10.2 Mycenax Biotech Inc. Product Introduction
  • 7.10.3 Mycenax Biotech Inc. Chronic Urticaria Or Hives Drug Production, Revenue (2015-2020)
  • 7.10.4 SWOT Analysis
• 7.11 Novartis AG
• 7.12 Panacea Biotec Limited

8 Conclusion